Jul 15, 2025, 09:06

SITC Fellowships Program

The Society for Immunotherapy of Cancer (SITC) Fellowships, funded via the SITC Forward Fund, award $100,000 USD one-year grants to early-career MD, PhD, or MD/PhD investigators advancing cancer immunotherapy research. Since 2014, over $6 million has been invested to cultivate the next generation of immuno-oncology experts.

Eligibility Criteria:

Membership: Must be a SITC Active Member in good standing—or have applied for membership—by the LOI deadline.
Career Stage: Early-career investigators (MD, PhD, or MD/PhD) pursuing clinical or translational immunotherapy research.
Fellowship Tracks:
- Genmab Translational Fellowship: Focus on DLBCL, FL, or CLL immunotherapy.
- Merck Clinical Fellowship: Clinical immunotherapy research.
- SITC Cancer Immunotherapy Fellowship: Broad clinical or translational immunotherapy studies.
Mentorship: Applicants must secure a Mentor’s Statement of Support.

Funding Details:

Amount: $100,000 USD per fellowship (Genmab, Merck, and SITC tracks).
Term: One year of salary support, research expenses, and mentorship.

Deadline & Application Process:

LOI Deadline: March 12, 2025 (Stage 1).
Stage 1 (LOI): Submit application form, project abstract, applicant biosketch, and Mentor’s Statement of Support.
Stage 2 (Full Application): Invited applicants provide statement of purpose, mentor’s biosketch, institutional support letter, detailed research plan and budget, facility description, and two references.
Notification: Stage 2 invitations and final decisions follow per SITC’s published timeline.

Where to Go for Further Information:

Fellowship Guidelines & Application: Download the 2025 SITC Fellowship Guidelines PDF from the SITC website.
Membership/Renewal: Join or renew.
Questions: [email protected] or [email protected] (for philanthropic inquiries).